Jove
Visualize
Contact Us

Related Concept Videos

Antibody Structure01:10

Antibody Structure

15.3K
15.3K
Antibody Structure01:10

Antibody Structure

69.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
69.5K
Cross-reactivity00:42

Cross-reactivity

34.1K
Overview
34.1K
Antibody Actions01:26

Antibody Actions

4.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
4.1K
Antibody Structure and Classes01:25

Antibody Structure and Classes

10.5K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
10.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Exploring potential strategies to enhance memory and cognition in aging mice.

F1000Research·2026
Same journal

Construction an Implicit Block Multi-Steps Approach for Solving Sixth-Order Fractional Differential Equations.

F1000Research·2026
Same journal

Kansei Engineering in the Evolving Service Sector: A Decade of Insights.

F1000Research·2026
Same journal

A Safety-First Mindset:  Role of Patient Safety Culture in Enhancing Healthcare Workers' Emotional Intelligence.

F1000Research·2026
Same journal

Decoding Decisions: Personality-Interest Motivational Sequences as Predictors of Career Paths.

F1000Research·2026
Same journal

Beyond the Transparent Barrier: A Domain Visualization and Integrative Review of Contemporary Research on Gender-Based Professional Stasis.

F1000Research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 18, 2026

A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood
08:17

A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood

Published on: February 8, 2016

11.2K

Working towards a consensus for antibody validation.

Peter D Reiss1, Danxi Min1, Mei Y Leung2

  • 1St John's Laboratory, London, SE8 5RT, UK.

F1000Research
|January 13, 2015
PubMed
Summary
This summary is machine-generated.

Commercial research antibodies often lack quality validation, leading to wasted resources and unreliable scientific results. The 1st International Antibody Validation Forum discussed improving antibody quality through data sharing and transparency.

More Related Videos

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
09:07

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

11.7K
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood
08:17

A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood

Published on: February 8, 2016

11.2K
Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
09:07

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

11.7K
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.4K

Area of Science:

  • Life Science Tools
  • Biotechnology
  • Immunology

Background:

  • Commercial research antibodies are vital in life science but frequently suffer from quality issues.
  • Substandard antibodies lead to wasted time, money, delayed research, and potentially irreproducible results.
  • This highlights a critical need for universal antibody validation standards.

Purpose of the Study:

  • To address the quality control challenges in the commercial antibody market.
  • To discuss the implications of inadequate antibody validation on scientific research.
  • To explore opportunities for enhanced quality and transparency in antibody production and use.

Main Methods:

  • The study summarizes discussions from the 1st International Antibody Validation Forum.
  • Scientists from academia and industry presented data on antibody quality issues.
  • Key issues and conclusions were identified through expert dialogue.

Main Results:

  • Significant quality problems exist in the commercial antibody market due to a lack of validation.
  • The forum identified current challenges and potential future solutions.
  • There is a recognized need for improved standards and practices.

Conclusions:

  • Universal standards for antibody validation are necessary to ensure research reliability.
  • Increased data disclosure and sharing can improve antibody quality and market transparency.
  • Addressing these issues is crucial for advancing scientific discovery and preventing publication of false results.